CME Group Bhd (7018) fair value: what the stock is really worth
As of Sep 21, 2026: fair value of CME Group Bhd MYR 0.00, price MYR 0.01, upside -14.0%, quality 43 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch CME Group Bhd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range 0.0050 MYR – 0.1450 MYR · fair‑value band 0.0042 MYR – 0.0045 MYR · the 0.0050 MYR price screens above the 0.0043 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow CME Group Bhd in your weekly email
Every Wednesday you see whether CME Group Bhd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
CME Group Berhad, an investment holding company, designs, manufactures, sells, and services firefighting and specialist vehicles in Malaysia. The company operates through four segments: Investment Holding, Manufacturing, Trading, and Others. It offers specialized mobility vehicles, and firefighting and safety vehicles.
Show more
CME Group Berhad, an investment holding company, designs, manufactures, sells, and services firefighting and specialist vehicles in Malaysia. The company operates through four segments: Investment Holding, Manufacturing, Trading, and Others. It offers specialized mobility vehicles, and firefighting and safety vehicles. The company also offers specialist vehicles, airport crash tenders, hazmat vehicles, aerial access ladder, cranes, fuel transfer vehicles, refuellers, riot control vehicles, fire rescue equipment, rescue equipment, and fixed installations. In addition, it services its firefighting and specialist vehicles; sale of related spare parts; sales and services of firefighting equipment, firefighting gas system, specialist and firefighting vehicles, and other safety related products; and designs, manufactures, and fire engine. Further, the company trades and deals in various pharmaceutical, medicinal, biological, and health supplement, and related health care products, as well as engages in property development. The company was incorporated in 1979 and is based in Subang Jaya, Malaysia.
Stock analysis
CME Group Bhd (7018) currently trades at 0.0050 MYR, while our model-based Fair Value estimate is 0.0043 MYR, implying the stock looks roughly 16.3% overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 0.0079 MYR per share, and 11 of the 24 models we run sit above the 0.0050 MYR price.
Bear case: the Asset-Based group reads lowest at 0.0011 MYR, and 13 of the 24 models stay below the price. Evidence for this calculation is low.
Scenario range: 0.0042 MYR (bear) to 0.0045 MYR (bull), the price of 0.0050 MYR sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 43/100 (below-average quality), in the Consumer Cyclical sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
CME Group Bhd reported revenue of 39.9M MYR in FY2025 versus 4.1M MYR in FY2020, a compound +57.3%/yr. Reported net income was 8.4M MYR in FY2025, compounding +27.4%/yr from FY2020.
Key figures
Market cap 6.0M MYR (≈ $1.5M) · P/S ratio 0.33 · Net margin 21.1% · Return on equity 1,717% · Return on assets (EBIT) 0.6% · Operating margin −6.0% · Revenue (TTM) 18.2M MYR · Revenue growth (YoY) −16.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).
What moves the price
The share trades about 67% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at −4% fair-value upside, at −14%, 7018 screens richer than that median.
Fair Value models
Bear 0.0042 MYRFair Value 0.0043 MYRBull 0.0045 MYR
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.67/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+46.7%
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.3%
’12
’13
’14
’15
’16
’17
’18
’19
’21
’23
’24
’25
What shareholders gained per year (last 5 years), in MYR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in MYR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+36.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+36.9%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.44% → 19%
⚠ Revenue per share shrinking 9.2%/yr over ~8Y (margin trend unclear) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+4.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Malaysia: IMF forecast 2.0% a year to 2030, 1.8% from 2016 to 2025) that is about +2.4% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Auto Manufacturers · 116 stocks
Beats the industry median on 2/8 measures
Overall it trails its industry peers.
Valuation
Quality Score43 · Below median
Fair Value upside−14% · Below median
Profitability
Return on assets2% · Below median
Net margin (TTM)−58% · Bottom 25%
Operating margin (TTM)−6% · Bottom 25%
Growth and dividend
Revenue growth−17% · Bottom 25%
Valuation Multiplesvs Auto Manufacturers median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "CME Group Bhd Fair Value". https://www.fairvalue-calculator.com/stock/7018
Frequently asked questions
Is CME Group Bhd (7018) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of 0.0043 MYR versus a price of 0.0050 MYR, about −14% upside (overvalued).
What is the fair value of 7018?
Our model-based fair value for CME Group Bhd is 0.0043 MYR (as of Sep 23, 2026), built from audited fundamentals. The current price: 0.0050 MYR.
What is the quality score of 7018?
CME Group Bhd has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for CME Group Bhd (7018)?
Our model-based price target is the fair value of 0.0043 MYR (as of Sep 23, 2026) from 24 valuation models. Cautious scenario 0.0042 MYR, optimistic scenario 0.0045 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the CME Group Bhd stock forecast for 2026?
Our models put fair value at 0.0043 MYR, about −14% upside versus a price of 0.0050 MYR (overvalued). Cautious scenario 0.0042 MYR, optimistic scenario 0.0045 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of CME Group Bhd (7018)?
CME Group Bhd reported trailing-twelve-month revenue of about 18.2M MYR (latest available figure, as of Sep 23, 2026).
What growth is priced into CME Group Bhd (7018)?
For today's price to be fair in a discounted-cash-flow model, CME Group Bhd would have to grow free cash flow by +4.4 % per year for five years (discount rate 9.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +57.3 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of 7018 use?
Our models discount CME Group Bhd at 9.7 %: a base by market capitalisation (nano), damped by beta 0.08, country premium for Malaysia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For CME Group Bhd that is +4.4 % per year a year over ten years, using the same discount rate (9.7 %) and the same formula as our fair value.
How much growth has CME Group Bhd (7018) delivered so far?
Over the past 5 years revenue at CME Group Bhd grew +57.3 % a year. The price currently implies +4.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of CME Group Bhd (7018) growing?
The median revenue growth in the sector is +2.6 % a year. That is the yardstick for the growth priced into CME Group Bhd (+4.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of CME Group Bhd (7018)?
The free-cash-flow yield on the price is 34.09 %: that much free cash flow CME Group Bhd produces per unit of market value. When it exceeds the discount rate of our models (9.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of CME Group Bhd (7018)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For CME Group Bhd it is 0.0043 MYR per share (as of Sep 23, 2026), against a price of 0.0050 MYR. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is CME Group Bhd stock overvalued or undervalued in 2026?
As of Sep 23, 2026, 7018 trades above its calculated fair value: price 0.0050 MYR, fair value 0.0043 MYR, a gap of about −14% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 7018?
No. The price is what the market pays today (0.0050 MYR); the fair value is what the company's own numbers justify (0.0043 MYR). For CME Group Bhd the two are 0.0007 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is CME Group Bhd worth?
The market values CME Group Bhd at about 6.0M MYR (market capitalisation, as of Sep 23, 2026). Per share that is 0.0050 MYR; our models calculate a fair value of 0.0043 MYR per share.
What do the bullish and bearish scenarios say about 7018?
Our models span a range for CME Group Bhd: cautious scenario 0.0042 MYR, base 0.0043 MYR, optimistic 0.0045 MYR per share (as of Sep 23, 2026, price 0.0050 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is 7018 from its 52-week high?
CME Group Bhd trades at 0.0050 MYR, about 67% below its 52-week high of 0.0150 MYR and at the low of 0.0050 MYR (as of Sep 21, 2026). Distance from the high says nothing about value: that is what the fair value of 0.0043 MYR is for.
Which stocks are comparable to CME Group Bhd?
From the same area (Consumer Cyclical) we also value Tesla, Inc, Toyota Motor Corporation, BYD Company, Hyundai Motor Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is CME Group Bhd stock attractive at the current price?
The data as of Sep 23, 2026: price 0.0050 MYR, calculated fair value 0.0043 MYR (−14%), Quality Score 43/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 7018 calculated?
We run CME Group Bhd through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.0043 MYR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. CME Group Bhd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of CME Group Bhd (7018)?
The closing price on Sep 21, 2026 was 0.0050 MYR. Our model-based fair value is 0.0043 MYR, about −14% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with CME Group Bhd right now?
The price sits above even our optimistic bull case (0.0045 MYR). The favourable scenario is already priced in. The models converge in a tight band (0.0042 MYR to 0.0045 MYR), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of CME Group Bhd
How large is the market capitalisation of CME Group Bhd (7018)?
The market capitalisation of CME Group Bhd is 6.0M MYR (≈ $1.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of CME Group Bhd (7018)?
The price-to-sales ratio of CME Group Bhd is 0.33 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of CME Group Bhd (7018)?
The net margin of CME Group Bhd is 21.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of CME Group Bhd (7018)?
The return on equity (ROE) of CME Group Bhd is 1,717% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of CME Group Bhd (7018)?
On an EBIT basis the return on assets of CME Group Bhd is 0.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of CME Group Bhd (7018)?
The operating margin of CME Group Bhd is −6.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at CME Group Bhd (7018)?
Revenue at CME Group Bhd is growing −16.8% versus a year earlier (3y avg +35.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at CME Group Bhd (7018)?
Earnings per share at CME Group Bhd are growing +65.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does CME Group Bhd (7018) carry?
The net debt of CME Group Bhd is 25.3M MYR (fiscal year 2025, ≈ 12.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch CME Group Bhd in the live analysis
One click puts CME Group Bhd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
